Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.38 |
| ▸ | TUBB | P07437 | 1/20 | 0.38 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.38 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.38 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.38 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3466529 | 1.00 | CYP2C19 (0.43) | CYP2C19KDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL18821936 | 0.89 | ALDH1A1 (0.41) | ALDH1A1CYP3A4IDO1 | |
| SCHEMBL256057 | 0.78 | CYP2C19 (0.47) | CYP2C19KDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL119646 | 0.78 | ALDH1A1 (0.52) | CYP2C19KDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL2093236 | 0.78 | GRIK1 (0.45) | CYP2C19KDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL2451125 | 0.78 | NFE2L2 (0.50) | GRIK1GRIK2 | |
| SCHEMBL9714638 | 0.78 | ALDH1A1 (0.52) | ALDH1A1GRIK1GRIK2CYP3A4IDO1 | |
| SCHEMBL1046101 | 0.78 | CYP2C19 (0.42) | CYP2C19KDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL7631405 | 0.78 | CYP2C19 (0.42) | CYP2C19KDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL5230246 | 0.78 | CYP2C19 (0.42) | CYP2C19KDM4EALDH1A1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132144-A1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-4446309-A2 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | Eisai R&D Management Co., Ltd. (JP) | 2024-10-16 | — | — | EP | disclosed |
| EP-3908587-B1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | EISAI R&D MAN CO LTD (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-20220112207-A1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2022-04-14 | — | — | US | disclosed |
| EP-3908587-A1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | Eisai R&D Management Co., Ltd. (JP) | 2021-11-17 | — | — | EP | disclosed |
| CN-113661166-A | Process for the synthesis of diazabicyclo [6.2.0] decane-related compounds | 卫材R&D管理有限公司 | 2021-11-16 | — | — | CN | disclosed |
| WO-2020146568-A1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-07-16 | — | — | WO | disclosed |
| WO-2010070076-A1 | ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2010-06-24 | — | — | WO | disclosed |
| EP-1268494-A1 | SULFUR SUBSTITUTED ARYLDIFLUOROMETHYLPHOSPHONIC ACIDS AS PTP-1B INHIBITORS | Merck Frosst Canada & Co. (CA) | 2003-01-02 | — | — | EP | disclosed |
| US-6498151-B2 | PROTEIN TYROSINE PHOSPHATASES INHIBITORS, ESPECIALLY AS ANTIDIABETIC AGENTS | MERCK FROSST CANADA & CO. (CA) | 2002-12-24 | — | — | US | disclosed |
| US-5597776-A | ANTAGONIST FOR HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-28 | — | — | US | disclosed |
| EP-0599906-B1 | HERBICIDES CONTAINING 3-AMINOBENZO B]THIOPHENES AS AN ANTIDOTE | BASF AG (DE) | 1997-01-15 | — | — | EP | disclosed |
| EP-0456069-B1 | Cyclohexenonoximethers, process and intermediates for their production and their usage as herbicides | BASF AG (DE) | 1996-10-23 | — | — | EP | disclosed |
| US-5563114-A | Cyclohexenone oxime ethers, their preparation, intermediates for their preparation and their use as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-08 | — | — | US | disclosed |
| US-5491123-A | Herbicides containing 3-aminobenzo(B)thiophenes as antidotes | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-13 | — | — | US | disclosed |
| US-5378677-A | Applying with cyclohexenone derivative | BASF AKTIENGESELLSCHAFT (DE) | 1995-01-03 | — | — | US | disclosed |
| EP-0599906-A1 | HERBICIDES CONTAINING 3-AMINOBENZO B]THIOPHENES AS AN ANTIDOTE. | BASF AG (DE) | 1994-06-08 | — | — | EP | disclosed |
| EP-0552493-A1 | Thiochromenone derivatives as antidotes and herbicidal agents containing them | BASF Aktiengesellschaft (DE) | 1993-07-28 | — | — | EP | disclosed |
| WO-1993004057-A2 | HERBICIDES CONTAINING 3-AMINOBENZO[B]THIOPHENES AS AN ANTIDOTE | BASF AKTIENGESELLSCHAFT (DE) | 1993-03-04 | — | — | WO | disclosed |
| EP-0456069-A1 | Cyclohexenonoximethers, process and intermediates for their production and their usage as herbicides | BASF Aktiengesellschaft (DE) | 1991-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220112207-A1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | AZI2, DECR1, DDT | CYP2C19 16/4885KDM4E 1433/4885ALDH1A1 1263/4885 |
| US-20260132144-A1 | METHOD FOR SYNTHESIS OF DIAZABICYCLO[6.2.0]DECANE RELATED COMPOUNDS | CYP2C9, ODC1, AOC2 | CYP2C19 43/4885KDM4E 2711/4885ALDH1A1 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.